Invitation to fourth quarter 2016 presentation

Posted on Feb 20, 2017

Oslo, 20 February 2017 – PCI Biotech invites to a presentation of the company’s fourth quarter 2016 report on Tuesday 28 February 2017 at Oslo Cancer Cluster Innovation Park. Time: Tuesday February 28, 11am – 12noon CET (local time). Venue: Jónas Einarsson aud. (2nd floor, entrance 2B), Oslo Cancer Cluster Innovation Park, Ullernchausséen 64, Oslo. […]

PCI Biotech awarded NOK 13.8 million from The Research Council of Norway to further development of PCI for use in vaccination

Posted on Jan 27, 2017

Oslo, Norway, January 27, 2017 PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that it has been awarded NOK 13.8 million in a BIA grant from The Research Council of Norway to the project “Photochemical vaccination – novel immunotherapy concept for treatment of cancer and infectious diseases”. […]

Capital increase registered and listing of new shares

Posted on Jan 19, 2017

Oslo, 19 January 2017, Reference is made to the previous announcements by PCI Biotech Holding ASA (“PCI Biotech” or the “Company”) in respect of the fully underwritten rights issue of 10,000,000 new shares in the Company (the “Rights Issue”). The share capital increase pertaining to the Rights Issue, resolved by the extraordinary general meeting on […]